Literature DB >> 28691681

Is it time to change NAFLD and NASH nomenclature?

Stefano Bellentani1, Claudio Tiribelli2.   

Abstract

Mesh：

Year:  2017        PMID： 28691681     DOI： 10.1016/S2468-1253(17)30146-2

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


× No keyword cloud information.
  7 in total

1.  Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis.

Authors:  Davide Povero; Eva M Pinatel; Aleksandra Leszczynska; Nidhi P Goyal; Takahiro Nishio; Jihoon Kim; David Kneiber; Lucas de Araujo Horcel; Akiko Eguchi; Paulina M Ordonez; Tatiana Kisseleva; Ariel E Feldstein
Journal:  JCI Insight       Date:  2019-06-11

Review 2.  Diagnostic management of nonalcoholic fatty liver disease: a transformational period in the development of diagnostic and predictive tools-a narrative review.

Authors:  Natalia Rosso; Adam M Stephenson; Pablo J Giraudi; Claudio Tiribelli
Journal:  Ann Transl Med       Date:  2021-04

Review 3.  History of Nonalcoholic Fatty Liver Disease.

Authors:  Amedeo Lonardo; Simona Leoni; Khalid A Alswat; Yasser Fouad
Journal:  Int J Mol Sci       Date:  2020-08-16       Impact factor: 5.923

4.  Metabolic-associated Fatty Liver Disease: Time to integrate ground-breaking new terminology to our clinical practice?

Authors:  Coskun Ozer Demirtas; Yusuf Yilmaz
Journal:  Hepatol Forum       Date:  2020-09-21

Review 5.  Non-alcoholic fatty liver disease (NAFLD) as a neglected metabolic companion of psychiatric disorders: common pathways and future approaches.

Authors:  Óscar Soto-Angona; Gerard Anmella; María José Valdés-Florido; Nieves De Uribe-Viloria; Andre F Carvalho; Brenda W J H Penninx; Michael Berk
Journal:  BMC Med       Date:  2020-10-01       Impact factor: 8.775

6.  An Experimental DUAL Model of Advanced Liver Damage.

Authors:  Raquel Benedé-Ubieto; Olga Estévez-Vázquez; Feifei Guo; Chaobo Chen; Youvika Singh; Helder I Nakaya; Manuel Gómez Del Moral; Arantza Lamas-Paz; Laura Morán; Nuria López-Alcántara; Johanna Reissing; Tony Bruns; Matías A Avila; Eva Santamaría; Marina S Mazariegos; Marius Maximilian Woitok; Ute Haas; Kang Zheng; Ignacio Juárez; José Manuel Martín-Villa; Iris Asensio; Javier Vaquero; Maria Isabel Peligros; Josepmaria Argemi; Ramón Bataller; Javier Ampuero; Manuel Romero Gómez; Christian Trautwein; Christian Liedtke; Rafael Bañares; Francisco Javier Cubero; Yulia A Nevzorova
Journal:  Hepatol Commun       Date:  2021-03-11

Review 7.  Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System.

Authors:  Pietro Torre; Benedetta Maria Motta; Roberta Sciorio; Mario Masarone; Marcello Persico
Journal:  Front Med (Lausanne)       Date:  2021-12-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.